20 Hidden Gem AI Stocks

4. PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

Number of Hedge Fund Holders: 21  

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is a surgical robotics company that focuses on developing transformative solutions in urology in the United States and internationally. The flagship AI product of the firm is the HYDROS Robotic System, which powers Aquablation therapy. This AI-integrated system enhances surgical planning and execution through real-time ultrasound and cystoscopy imaging. Within the system is FirstAssist AI, a platform that uses image recognition software to help surgeons identify critical areas of the prostate and suggest optimal treatment plans tailored to the patient’s anatomy. This AI-driven approach improves patient outcomes and reduces the variability often seen in surgical results.

TD Cowen recently raised the price target on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) stock to $99 from $75 and kept a Buy rating on the shares. The advisory said the recent 30% stock appreciation following its FDA approval was justified since Hydros could spark a multiyear new product cycle that enhanced the current revenue growth trajectory.